| |

Mesothelioma Patients Underrepresented in European National Cancer Data

Mesothelioma Patients Underrepresented in European National Cancer DataCancer patient surveys are important for improving healthcare practice and policy. A new study suggests mesothelioma patients may be underrepresented in this important survey.

The goal of the National Cancer Patient Experience Survey is to improve European cancer care. In order to be useful, this survey should represent all cancer patients.

Cancer Patient Data Collection using a National Survey

Patient feedback from healthcare services is important for informing healthcare quality. And data from patient surveys directly impact policy to improve care.

In the United Kingdom, there are many surveys that collect information on patient experiences. For people with cancer, a National Cancer Patient Experience Survey has been taken annually for the last 12 years. It surveys over 65,000 people with cancer.

A new study looked at how mesothelioma patient respondents represent the overall population. They looked at demographics, clinical data, treatments, and survival outcomes. They compared the entire mesothelioma population with this one national survey.

Mesothelioma Population Underrepresented

More than 2,700 people are diagnosed with mesothelioma each year in the United Kingdom. Approximately 10% of people diagnosed with mesothelioma are included in the annual survey.

Older patients and those with a later stage of cancer were not well represented in the survey data. Also, those with multiple comorbidities or worse diagnoses were not well-represented.

Gender was represented well. But people with nonwhite ethnicity and from more deprived socioeconomic groups were underrepresented.

Mesothelioma patients with chemo-radiotherapy were very well represented in the survey data. But patients who do not receive anti-cancer treatment were very under-represented.

Overall, the national data was an unbalanced representation when compared with the national mesothelioma population.

In Conclusion

National data is used to inform mesothelioma policy and research. It is important that all survey results represent the population as closely as possible.

This new study suggests mesothelioma patients may be underrepresented in the National Survey.

This under-representation should be identified when using survey data for advancing cancer care.

Source:

Yvonne Nartey, Iain Stewart, Vanessa Beattie, Andrew Wilcock, Paul Beckett, Richard Hubbard, Laila J Tata. Are people with mesothelioma who respond to the English Cancer Patient Experience Survey representative of the national mesothelioma population? A data comparison with cancer registry patients from the National Lung Cancer Audit, International Journal of Nursing Studies Advances (2022), https://doi.org/10.1016/j.ijnsa.2022.100077

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • |

    Mesothelioma Rates Expected to Rise for Another Decade

    Most developed countries can expect another decade or more of rising mesothelioma rates before the incidence of the disease starts to wane. That is one of the major findings in a recent report from The Baird Institute for Applied Heart and Lung Surgical Research in Australia. The report, which looked at the causes, distribution and projected future incidence of malignant mesothelioma, contains both good and bad news for the U.S.. Mesothelioma is an aggressive and often fatal cancer caused by exposure to asbestos.  It is thought to be triggered by chronic inflammation and irritation in the lung tissue and the surrounding pleural membrane by the sharp asbestos fibers.   Mesothelioma often takes decades to develop. According to the Baird Institute report, the average…